Apremilast in Reducing Ulcer Frequency and Severity in a 2‐Year‐Old Child With Recurrent Aphthous Stomatitis
Pediatric Dermatology · 2026-11-05
DOI: 10.1111/pde.70397 ↗At a glance
Fallbericht in Pediatric Dermatology, published online on 2026-11-05. Written by Tinglan Yang and 2 co-authors. Institution: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Labora…. 4 references.
Abstract (original language)
This case report describes a 2‐year‐old boy with recurrent oral ulcers over 6 months, requiring up to 2 weeks to heal and reaching 8–10 mm in diameter. After excluding Behçet's disease and other conditions, recurrent aphthous stomatitis was diagnosed. Apremilast was initiated with gradual dose escalation to 10 mg twice daily, leading to a significant reduction in ulcer frequency and severity. This case suggests apremilast may be a viable option for very young children with severe recurrent aphthous stomatitis, though careful dose titration and monitoring are essential.
Authors and institutions
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral Medicine, School of Stomatolog…
ORCID profiles: Tinglan Yang, Qing Liu, Zhenlai Zhu
Cite
APA
Yang, T., Liu, Q., & Zhu, Z. (2026). Apremilast in Reducing Ulcer Frequency and Severity in a 2‐Year‐Old Child With Recurrent Aphthous Stomatitis. Pediatric Dermatology. https://doi.org/10.1111/pde.70397
Vancouver
Yang T, Liu Q, Zhu Z. Apremilast in Reducing Ulcer Frequency and Severity in a 2‐Year‐Old Child With Recurrent Aphthous Stomatitis. Pediatric Dermatology. 2026. doi:10.1111/pde.70397
BibTeX
@article{Yang2026,
author = {Yang, Tinglan and Liu, Qing and Zhu, Zhenlai},
title = {Apremilast in Reducing Ulcer Frequency and Severity in a 2‐Year‐Old Child With Recurrent Aphthous Stomatitis},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70397}
}
EUVIMED